SOURCE: Biovation

Biovation

March 24, 2015 05:00 ET

Biovation Launches BioArmour™ Blood Pressure Cuff Shield, an Infectious Disease Barrier Product for Hospitals and Healthcare Facilities

Blood Pressure Cuff Shield From Biovation Offers an Antimicrobial Hygienic Barrier Against Hospital Acquired Infections; Medical Product Is Now Available to European and Canadian Markets

BOOTHBAY, ME--(Marketwired - Mar 24, 2015) - Biovation has launched the BioArmour Blood Pressure Cuff Shield (BPCS) to mitigate the spread of infectious pathogens from blood pressure cuffs. This first-in-class medical product offers a multi-use barrier for prevention of hospital acquired infections (HAIs). The BPCS has been designed, tested and validated over a two-year cycle, and is now available in European, Canadian and all non-US markets. BioArmour is the first in a suite of infection and pathogen control products from Biovation.

In lab testing, the latex-free BioArmour BPCS has been shown to kill up to 99.99% of tested microorganisms, including MRSA, VRE, c. difficile and others. The BPCS is manufactured from a sustainable biopolymer and impregnated with antimicrobial and antifungal agents. Sciessent partnered with Biovation to develop the antimicrobial technology.

BPCS attaches to the blood pressure cuff to prevent direct contact of the cuff with the patient's skin, and does not adversely impact accuracy of blood pressure measurement data. BPCS provides another tool for risk mitigation for hospitals and healthcare facilities with proactive measures for infectious disease reduction and control. This cost-effective system can be used by multiple patients in a 24-hour period in outpatient and in-patient environments, physician offices, hospice and nursing home facilities and emergency medical services.

The BioArmour BPCS has been registered a CE Class I medical device marked for distribution in the EU. As a medical product, it is available for sale in Canada and all other non-US countries. US FDA approval is anticipated for late summer 2015. For full details visit http://biovation.com/category/news/.

About Sciessent, LLC
Sciessent is a leading provider of customized antimicrobial solutions that enhance the value of customers' products; please visit www.sciessent.com. Agion antimicrobial solutions from Sciessent have been incorporated into a wide range of healthcare applications, including medical devices such as central-venous catheters and IV access ports.

About Biovation II, LLC
Biovation is a technology design and manufacturing company that manufactures advanced non-woven fiber products with integrated antimicrobial properties for packaging, healthcare, custom advanced material OEM products, and other specialty scalable applications. For more information, call +1.207.633.0616 or visit www.biovation.com.

Contact Information